Assessing the value of cardiac biomarkers: going beyond diagnostic accuracy?
Amy Durtschi and Paul Jülicher review current approaches to assessing cost-effectiveness in cardiac laboratory tests. This review, from Future Cardiology, is free to access exclusively for Evidence Base members.
Please sign in or register for FREE
Sign in to The Evidence Base
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>